AtriCure
ATRC
141 hedge funds and large institutions have $1.13B invested in AtriCure in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 18 closing their positions.
30% more capital invested
Capital invested by funds: $872M → $1.13B (+$263M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
20% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 45
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
0% more funds holding
Funds holding: 141 → 141 (0)
0.32% less ownership
Funds ownership: 88.56% → 88.24% (-0.32%)
31% less call options, than puts
Call options by funds: $474K | Put options by funds: $685K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$16.3M |
| 2 |
Millennium Management
New York
|
+$12.7M |
| 3 |
BM
Bridger Management
New York
|
+$7.44M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$5.15M |
| 5 |
O
OrbiMed
New York
|
+$4.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$12.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.91M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$6.69M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$4.07M |
| 5 |
OCM
Osterweis Capital Management
San Francisco,
California
|
-$4.06M |
ATRC Hedge Fund Activity: Q4 2019 in Review
141 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2019, worth a combined $1.13B — up 30% from $872M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ATRC positions and 18 closed out — a net gain of 1 holder — while 54 added to existing stakes and 45 trimmed.
The largest buyer was Champlain Investment Partners, adding an estimated $16.3M. The largest seller was Loomis, Sayles & Company, cutting an estimated $12.2M.
- 141 institutional investors held AtriCure (ATRC) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $1.13B of AtriCure stock for Q4 2019, up 30% quarter-over-quarter.
- 19 funds opened new AtriCure positions in Q4 2019 and 18 closed out, a net change of +1 holder.
- The largest AtriCure buyer in Q4 2019 was Champlain Investment Partners, an estimated $16.3M added.
- The largest AtriCure seller in Q4 2019 was Loomis, Sayles & Company, an estimated $12.2M sold.
Based on aggregated 13F filings for Q4 2019.